Helius Medical Technologies, Inc. to Present at the Planet MicroCap Showcase on April 21st
April 15 2021 - 8:35AM
Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius”
or the “Company”), a neurotech company focused on neurological
wellness, today announced that management will participate in the
Planet MicroCap Showcase, which is being held virtually from April
20th-22nd. Management will present on Wednesday, April 21st at 8:30
a.m. Eastern Time.
A live audio webcast of the conference
presentation will be available under the ‘Events’ section of the
Helius Medical Technologies investor relations website at
https://heliusmedical.com/index.php/investor-relations/events/upcoming-events.
An archive of the webcast will be available following the
conference.
About Helius Medical Technologies, Inc.
Helius Medical Technologies is a neurotech
company focused on neurological wellness. The Company’s purpose is
to develop, license and acquire unique and non-invasive platform
technologies that amplify the brain’s ability to heal itself. The
Company’s first commercial product is the Portable Neuromodulation
Stimulator (PoNS™). For more information, visit
www.heliusmedical.com.
About the PoNS™ Device and PoNS Treatment™
The Portable Neuromodulation Stimulator (PoNS™) is an innovative
non-surgical medical device, inclusive of a controller and
mouthpiece, which delivers mild electrical stimulation to the
surface of the tongue to provide treatment of gait deficit and is
indicated for use in the United States as a short term treatment of
gait deficit due to mild-to-moderate symptoms from multiple
sclerosis (MS) and is to be used as an adjunct to a supervised
therapeutic exercise program in patients 22 years of age and over
by prescription only. The PoNS device is authorized for sale in
Canada as a class II, non-implantable, medical device intended as a
short term treatment (14 weeks) of gait deficit due to mild and
moderate symptoms from MS, and chronic balance deficit due to
mild-to-moderate traumatic brain injury (mmTBI) and is to be used
in conjunction with physical therapy. The PoNS device is an
investigational medical device in the European Union (“EU”) and
Australia (“AUS”). It is currently under premarket review by the
AUS Therapeutic Goods Administration.
Investor Relations Contact:
Westwicke on behalf of Helius Medical Technologies, Inc.Jack
Powell, Vice Presidentinvestorrelations@heliusmedical.com
Helius Medical Technolog... (NASDAQ:HSDT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Helius Medical Technolog... (NASDAQ:HSDT)
Historical Stock Chart
From Sep 2023 to Sep 2024